Industry Insights Seminar Series
The Industry Insights Seminar Series is hosted by the Business Partnerships Office and sponsored by the BioEscalator.
- First Tuesday of every month
- 12.00 -1.00 pm
- Via Zoom
- Networking & 1:1 meeting opportunities
Selected industry speakers provide seminars that are scientific in nature, across a range of medical or health topics. Speakers are encouraged to bring along colleagues providing the opportunity to, not only attend a scientific seminar of interest, but also to network with industry scientists. One to one meetings can be facilitated upon request. Seminars are suitable for all academics with some knowledge or interest in each topic area, from PhD students to PIs. Although mostly aimed at an academic audience, those located in the BioEscalator and Wood Centre, as well as local spinouts, are welcome to attend.
Please check the format of each talk before registering, as we will adapt to virtual or in-person seminars dependent upon the changing Covid-19 circumstances.
4th May 2021: Improving drug delivery in ophthalmology
Presenter: Joanna Gould - CEO, VisusNano
Abstract: VisusNano Ltd. is a pre-clinical company developing a pipeline of novel drug-eluting intraocular lens implant for use in patients undergoing cataract surgery. By improving patient outcomes, obviating the need for eye drops after surgery, and avoiding the need for laser treatment after surgery, our project has the potential to revolutionise cataract surgery in both the human and veterinary markets.
Changes to the event format
These events are usually in person at the BioEscalator. However, due to Covid-19, these seminars will be given virtually. Once back in person there will be limited in-person tickets for BioEscalator tenants, please contact Elodie Siney/reception if you would like to secure an in-person place.
If you have an industry partner you would like to invite to speak, please contact Sheena Lee.
6th April 2021: Accelerating Covid-19 Antibody Discovery through Industry-Academia Consortium
Company: BioIndustry Association (BIA)
Presenter: Jane Osbourn OBE, CSO Alchemab and Paul Kellam VP infectious diseases and vaccines, Kymab.
2nd March 2021: Transforming the Path for Equitable Access to Rapid Diagnostics for Epidemics
Presenter: Joe Fitchett - Medical Director
2 February 2021: Targeting the Aryl Hyrdrocarbon Receptor (AHR) as a Novel Immunotherapy for the Treatment of Cancer
Company: Bayer AG
Presenter: Dr Ilona Gutcher - Group Leader Oncology
5 January 2021: Exosome-Based Therapies for the Treatment of Rare Genetic Diseases
Company: Evox Therapeutics
Presenter: David Lowe - Vice President, Research
6 October 2020: Maintaining Human Livers Outside Of The Body: From Advances In Transplant Medicine To Developing Liver Nash Therapies
Company: Ochre Bio & OrganOx
Presenters: Quin Wills & Jack O'Meara, CSO and CEO Ochre Bio and Andy Self, Commercial Director at OrganOx
1 September 2020: Biotherapeutic Medicines From Botulinum Neurotoxins
Presenter: Matthew Beard
7 July 2020: Translational Science & Medicine In Industry
Company: Janssen R&D
Presenter: Luke Devey, VP Translational science
2 June 2020: A Multi-Omics Approach For Type 2 Diabetes Target Discovery: Identification And Characterisation Of Disease-Specific Small Open Reading Frame Encoded Peptides
Company: Novo Nordisk
Presenter: Dr. Bill Haynes, Site Head and Vice President, Novo Nordisk Research Centre Oxford
3 March 2020: Deep Learning Based Image Enhancement In Positron Emission Tomography
Company: GE Healthcare
Presenter: Dr Abolfazl Mehranian - Imaging Scientist
4 February 2020: What Disease? – Do We Have The Right Approach To Disease Classification And How This Should Impact Our Approach To Treatment
Company: Sensyne Health
Presenter: Dr Rabia Khan - Chief of Translational Medicine
7 January 2020: Utility Of Non-Invasive Image Derived Biomarkers To Characterise Health And Disease: Advances Towards Personalised Medicine
Company: Perspectum Diagnostics Ltd
Presenter: Dr Andrea Dennis - Head of Biomarker Sciences
4 December 2019: When Less Is More - A New Twist To GalNAc-Conjugated siRNA For Treatment Of Liver-Related Disorders
Company: Silence Therapeutics
Presenter: Dr Marie Wikstrom Lindholm - VP Head of Technology Innovation